During the past decade, Infectious Disease of Indiana conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infectious Disease of Indiana" #1 sponsor was "Astellas Pharma Inc" with 3 trials, followed by "Arpida AG" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cytran" with 1 trials sponsored and "Glaxo Wellcome" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Disease of Indiana" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator and "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Infectious Disease of Indiana" are "HIV Infections" (3 trials), "Aspergillosis" (2 trials), "Candidemia" (1 trials), "Candidiasis, Invasive" (1 trials) and "Complicated Skin and Skin Structure Infection" (1 trials). Many other conditions were trialed in "Infectious Disease of Indiana" in a lesser frequency.

Most popular intervention types in "Infectious Disease of Indiana" are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Isavuconazole" (2 trials), "Voriconazole" (2 trials), "Atazanavir" (1 trials), "Caspofungin" (1 trials) and "Conventional Wound Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Disease of Indiana" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Infectious Disease of Indiana". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Infectious Disease of Indiana, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Disease of Indiana, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".